Plain-English translation of NCT05132348 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are trying to understand how the immune system is involved in osteoporosis—a disease where bones become weaker and more likely to break. By studying blood samples from people with osteoporosis, they hope to discover immune markers that could lead to better ways of diagnosing the condition and developing new treatments.
Current treatments for osteoporosis don't work well for everyone and can have serious side effects. Scientists have discovered that osteoporosis involves inflammation in the body, so understanding the immune system's role could unlock entirely new treatment approaches.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will donate a blood sample that researchers will analyze to study your immune system markers. The study is observational, meaning researchers are collecting and studying information rather than testing a new medication on you. Your participation helps build a database of immune markers in people with osteoporosis that may lead to better treatments in the future.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Germany
Enrollment target
~250 participants
Started
October 2021
Primary completion
February 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in November 2021.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Andreas Strauß, PD Dr.
physican
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.